SCHEMBL13845183

SCHEMBL13845183

CNc1nc(CO)c(N)c(NCc2c(Cl)cccc2Cl)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 1/20 0.41
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ JAK2 O60674 5/20 0.37
▸ JAK3 P52333 5/20 0.37
▸ JAK1 P23458 4/20 0.37
▸ BCHE P06276 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ KDM1A O60341 2/20 0.36
▸ RCOR1 Q9UKL0 2/20 0.36
▸ SMOX Q9NWM0 1/20 0.36
▸ HRH4 Q9H3N8 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ CDK5 Q00535 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13845176 0.80 JAK2 (0.44) CSF1RJAK2JAK3JAK1LMNA
SCHEMBL19929868 0.69 JAK2 (0.43) MEN1KMT2AJAK2BCHEACHE
SCHEMBL22754163 0.68 EIF2AK1 (0.38) CSF1RMEN1KMT2ABCHEACHE
SCHEMBL11148663 0.64 MAPT (0.46) MEN1KMT2AJAK2JAK3JAK1
SCHEMBL11291747 0.64 CD38 (0.47) MEN1KMT2AJAK2JAK3JAK1
SCHEMBL19929931 0.63 LMNA (0.38) CSF1RJAK2JAK3JAK1LMNA
SCHEMBL28137002 0.62 CSF1R (0.49) CSF1RHDAC3HDAC1HDAC2HDAC6
SCHEMBL12651376 0.62 LRRK2 (0.38) JAK2
SCHEMBL15553220 0.61 CSF1R (0.57) CSF1RMEN1KMT2AJAK2JAK3
SCHEMBL9232504 0.61 KMT2A (0.41) MEN1KMT2ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009062059-A2 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PHARMACOPEIA, INC. (US) 2009-05-14 — — WO disclosed
Send feedback